GHRP-2, or Growth Hormone Releasing Peptide-2, is a synthetic growth-hormone secretagogue. It is a short peptide that acts on the ghrelin (growth hormone secretagogue) receptor to prompt the pituitary to release growth hormone.

How does GHRP-2 work?

GHRP-2 works primarily through ghrelin-receptor-mediated growth-hormone release. By engaging the ghrelin system rather than supplying growth hormone directly, it can also influence appetite signaling.

What does research suggest about GHRP-2?

GHRP-2 has a history of use as a pharmacological research tool, and preclinical studies document its growth-hormone-releasing effects. Human evidence is limited, and it is not an approved therapy, so clinical benefits and long-term outcomes remain poorly characterized.

Is GHRP-2 approved or legal?

GHRP-2 is not an approved medicine for general use and is generally handled as a research chemical. It is not licensed as a treatment, and its regulatory status varies by jurisdiction.

What are the side effects of GHRP-2?

Commonly reported effects include increased appetite and water retention, consistent with its action on the ghrelin receptor. Because it alters the growth-hormone axis, it carries real hormonal risks.

GHRP-2 is not a validated therapy, and manipulating the growth-hormone axis carries genuine risks. It has not been established as safe for general human use, and this reference is educational rather than medical advice.

How is GHRP-2 different from GHRP-6?

Both are synthetic ghrelin-receptor growth-hormone secretagogues from the same research family. The most commonly discussed difference is appetite: GHRP-6 is notorious for a strong hunger effect, while GHRP-2 is generally described as having a somewhat milder appetite response. Both remain unapproved research compounds, and neither is a validated therapy.

Is GHRP-2 the same thing as ghrelin or a 'natural' hormone?

No. GHRP-2 is a fully synthetic peptide that happens to act on the same receptor as ghrelin, the body's natural hunger-and-GH hormone. It was actually developed before ghrelin itself was discovered. Acting on a natural receptor does not make a compound 'natural' or make its effects well-characterised or safe.

Why is GHRP-2 often paired with a GHRH-type peptide in discussions?

In research and forum discussion GHRP-2 is frequently mentioned alongside GHRH-analog peptides because they act through separate pathways on the GH axis. This is context, not guidance: peptides.cx does not provide protocols, combinations, or dosing, and none of this implies any use is safe or effective.

Where can I buy GHRP-2 and compare vendors?

Use the vendor comparison on this page. It shows only checked, product-specific links and identifies vendor claims, independent documentation and affiliate relationships separately. Availability and legal status can vary by country.

Growth Hormone Secretagogue

Buy GHRP-2 – Vendors, Prices, Testing and Evidence

Buy GHRP-2

Also known as: Growth Hormone Releasing Peptide-2

Evidence grade C — Early / PreclinicalRisk flag

Short answer

A growth-hormone-releasing peptide with limited human evidence and hormonal risks.

Where can you buy GHRP-2?

Crystal Peptides. The table lists only product-specific offers that were checked and for which a real destination exists. Missing prices, quantities, stock and laboratory details are not inferred.

What is known?

GHRP-2 is a synthetic growth-hormone secretagogue.

What is not established?

Some pharmacological study history; not an approved therapy.

Safety

Hormonal effects carry real risks; not a validated therapy.

Regulatory status

Not an approved medicine for general use. Research chemical status.

Not medical advice. This educational reference is not diagnosis, treatment, prescribing, dosing or emergency guidance. Consult a qualified professional before making health-related decisions.

Regulatory or safety concern: This substance may be unapproved for human use, affect the hormonal system, or be subject to regulator or anti-doping restrictions. Check the cited evidence and rules in your jurisdiction.

Vendor comparison

Buy GHRP-2: compare vendors

The table lists only product-specific offers that were checked and for which a real destination exists. Missing prices, quantities, stock and laboratory details are not inferred.

Vendor	Product	Documentation	Shipping	Checked	Action
Crystal Peptides Code PEPTIDES10 −10% · discount code details Sponsored	GHRP-2 research product	Vendor-supplied data COA stated as available Not independently documented	Europe See the localized country store	Jul 18, 2026	View at vendor

Crystal Peptides

GHRP-2 research product

Code PEPTIDES10 −10% · discount code details

What is it?

GHRP-2 is a synthetic growth-hormone secretagogue.

Research and evidence

GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic growth-hormone secretagogue: a short peptide designed to prompt the pituitary gland to release its own stored growth hormone. It belongs to the same functional family as GHRP-6 and other ghrelin-mimetic peptides. Rather than supplying growth hormone directly, GHRP-2 acts on the growth hormone secretagogue (ghrelin) receptor, and this ghrelin-receptor-mediated pathway is the mechanism most consistently described in the literature. Because it engages the ghrelin system, GHRP-2 also influences appetite signaling, which is one of its most frequently reported effects.

GHRP-2 is studied because it offers a way to probe how the growth-hormone axis can be stimulated pharmacologically. It has a history of use as a pharmacological research tool and in mechanistic studies of GH secretion, and preclinical (animal) work has documented its GH-releasing effects. That said, the honest evidence picture is limited: GHRP-2 is not an approved medicine for general use, human data are far more constrained than for established therapies, and much of what is known about downstream outcomes comes from animal or short-term pharmacological settings rather than large, controlled clinical trials. On peptides.cx it carries an evidence rating of C, reflecting that its biological activity is real but its clinical value and long-term safety are not well validated.

Safety is a genuine consideration. Manipulating the growth-hormone axis carries real hormonal risks, and GHRP-2 is not a validated therapy. Commonly reported effects include increased appetite and water retention, consistent with its ghrelin-receptor activity. Its regulatory standing is that of a research chemical rather than a licensed drug, and it is not approved for human treatment in general use. This page is an educational reference intended to summarize what the science does and does not show; it is not medical advice and does not provide dosing, protocols, or sourcing. Anyone evaluating GHRP-2 should treat the current evidence as preliminary and consult qualified professionals for health decisions.

Evidence grade: C

Some pharmacological study history; not an approved therapy. Preclinical GH-release effects documented.

Human evidence

Some pharmacological study history; not an approved therapy.

Animal and preclinical evidence

Preclinical GH-release effects documented.

Proposed mechanisms

Ghrelin-receptor-mediated growth-hormone release

Safety concerns and known side effects

Hormonal effects carry real risks; not a validated therapy.

Increased appetite
Water retention reported

Regulatory status

Not an approved medicine for general use. Research chemical status.

GHRP-2 research timeline

1980s
GHRP-2 emerges from a line of synthetic growth-hormone-releasing peptides developed largely from Cyril Bowers' work on enkephalin-derived compounds that stimulated GH release.
Early 1990s
GHRP-2 (also designated KP-102 / pralmorelin) is characterised in pharmacological studies as a potent, orally and injectably active GH secretagogue.
Mid-late 1990s
The growth-hormone secretagogue receptor (GHS-R) is identified, later shown to be the ghrelin receptor, explaining the mechanism through which GHRP-2 acts — years before its natural ligand was known.
1999
Discovery of ghrelin, the endogenous ligand of the receptor GHRP-2 targets, reframes GHRP-2 as a synthetic ghrelin-mimetic secretagogue.
2000s
GHRP-2 (pralmorelin) is studied and, in Japan, used as a diagnostic agent to provoke GH release when assessing growth-hormone deficiency; it is not approved as a general therapy.
2010s-2020s
GHRP-2 circulates widely on the research-chemical market as a 'GH peptide'; regulators and anti-doping bodies flag GH secretagogues, and it remains an unapproved, prohibited-in-sport compound rather than a validated treatment.

Frequently asked questions about GHRP-2

What is GHRP-2?: GHRP-2, or Growth Hormone Releasing Peptide-2, is a synthetic growth-hormone secretagogue. It is a short peptide that acts on the ghrelin (growth hormone secretagogue) receptor to prompt the pituitary to release growth hormone.
How does GHRP-2 work?: GHRP-2 works primarily through ghrelin-receptor-mediated growth-hormone release. By engaging the ghrelin system rather than supplying growth hormone directly, it can also influence appetite signaling.
What does research suggest about GHRP-2?: GHRP-2 has a history of use as a pharmacological research tool, and preclinical studies document its growth-hormone-releasing effects. Human evidence is limited, and it is not an approved therapy, so clinical benefits and long-term outcomes remain poorly characterized.
Is GHRP-2 approved or legal?: GHRP-2 is not an approved medicine for general use and is generally handled as a research chemical. It is not licensed as a treatment, and its regulatory status varies by jurisdiction.
What are the side effects of GHRP-2?: Commonly reported effects include increased appetite and water retention, consistent with its action on the ghrelin receptor. Because it alters the growth-hormone axis, it carries real hormonal risks.
Is GHRP-2 safe?: GHRP-2 is not a validated therapy, and manipulating the growth-hormone axis carries genuine risks. It has not been established as safe for general human use, and this reference is educational rather than medical advice.
How is GHRP-2 different from GHRP-6?: Both are synthetic ghrelin-receptor growth-hormone secretagogues from the same research family. The most commonly discussed difference is appetite: GHRP-6 is notorious for a strong hunger effect, while GHRP-2 is generally described as having a somewhat milder appetite response. Both remain unapproved research compounds, and neither is a validated therapy.
Is GHRP-2 the same thing as ghrelin or a 'natural' hormone?: No. GHRP-2 is a fully synthetic peptide that happens to act on the same receptor as ghrelin, the body's natural hunger-and-GH hormone. It was actually developed before ghrelin itself was discovered. Acting on a natural receptor does not make a compound 'natural' or make its effects well-characterised or safe.
Why is GHRP-2 often paired with a GHRH-type peptide in discussions?: In research and forum discussion GHRP-2 is frequently mentioned alongside GHRH-analog peptides because they act through separate pathways on the GH axis. This is context, not guidance: peptides.cx does not provide protocols, combinations, or dosing, and none of this implies any use is safe or effective.
Where can I buy GHRP-2 and compare vendors?: Use the vendor comparison on this page. It shows only checked, product-specific links and identifies vendor claims, independent documentation and affiliate relationships separately. Availability and legal status can vary by country.

Common discussion areas

GH axisAppetite

Compare GHRP-2

GHRP-2 vs GHRP-6 GHRP-2 vs Hexarelin

Sources

Editorial review and transparency

Written by: peptides.cx Editorial Team
Scientific reviewer: No named medical reviewer is currently assigned
Last editorial review: June 1, 2026
Last vendor check: July 18, 2026
Review method: Source review, claim verification, vendor-data separation and regulatory-context review.
Commercial disclosure and conflicts: Vendor relationships do not determine evidence or safety ratings. No named reviewer conflict is recorded because no named reviewer is assigned.

Editorial policy →Evidence grade →Vendor methodology →

Related on peptides.cx

Library →Vendor quality checklist →Safety →Affiliate code: PEPTIDES10